Blackrock Health Sciences Trust
Last updated September 27, 2026
Organization details
- Legal name
- Blackrock Health Sciences Trust
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- BME
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001314966
Board of directors
- Since 2023
Board connections
1 of this board's directors also sit on 35 other boards.
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
- via Arthur Philip Steinmetz
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 30, 2026 | Liu Xiang Portfolio Manager | Option exercise | +389 | โ | โ |
| Jan 30, 2026 | Xie H Erin Portfolio Manager | Option exercise | +11,450 | โ | โ |
| Jan 30, 2026 | Liu Xiang Portfolio Manager | Sold back to the company | โ389 | $41.87 | $16,292 |
| Jan 30, 2026 | Xie H Erin Portfolio Manager | Sold back to the company | โ11,450 | $41.87 | $479,391 |
| Jan 31, 2025 | Xie H Erin Portfolio Manager | Option exercise | +13,471 | โ | โ |
| Jan 31, 2025 | Liu Xiang Portfolio Manager | Option exercise | +281 | โ | โ |
| Jan 31, 2025 | Accettella Christopher Portfolio Manager | Option exercise | +202 | โ | โ |
| Jan 31, 2025 | McClements Kyle Portfolio Manager | Option exercise | +641 | โ | โ |
| Jan 31, 2025 | Xie H Erin Portfolio Manager | Sold back to the company | โ13,471 | $40.92 | $551,239 |
| Jan 31, 2025 | Liu Xiang Portfolio Manager | Sold back to the company | โ281 | $40.92 | $11,499 |
| Jan 31, 2025 | Accettella Christopher Portfolio Manager | Sold back to the company | โ202 | $40.92 | $8,267 |
| Jan 31, 2025 | McClements Kyle Portfolio Manager | Sold back to the company | โ641 | $40.92 | $26,248 |
| Jan 31, 2024 | McClements Kyle Portfolio Manager | Option exercise | +626 | โ | โ |
| Jan 31, 2024 | Xie H Erin Portfolio Manager | Option exercise | +14,947 | โ | โ |
| Jan 31, 2024 | Accettella Christopher Portfolio Manager | Option exercise | +203 | โ | โ |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.